Brooklyn Stock Future Price Prediction

BTX
 Stock
  

USD 0.64  0.05  8.47%   

Brooklyn Immunotherapeuti stock price prediction is an act of determining the future value of Brooklyn Immunotherapeuti shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Brooklyn Immunotherapeuti's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Brooklyn Immunotherapeuti and does not consider all of the tangible or intangible factors available from Brooklyn Immunotherapeuti's fundamental data. We analyze noise-free headlines and recent hype associated with Brooklyn Immunotherapeutics, which may create opportunities for some arbitrage if properly timed.
Continue to Brooklyn Immunotherapeuti Basic Forecasting Models to cross-verify your projections.
  
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Brooklyn Immunotherapeuti based on different types of headlines from major news networks to social media. The Brooklyn stock price prediction module provides an analysis of price elasticity to changes in media outlook on Brooklyn Immunotherapeuti over a specific investment horizon.
EPS Estimate Current Year
-0.56
EPS Estimate Next Year
-0.5
Wall Street Target Price
3.5
EPS Estimate Current Quarter
-0.14
Using Brooklyn Immunotherapeuti hype-based prediction, you can estimate the value of Brooklyn Immunotherapeutics from the perspective of Brooklyn Immunotherapeuti response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Brooklyn Immunotherapeuti using Brooklyn Immunotherapeuti's options and short interest. It helps to benchmark the overall future attitude of investors towards Brooklyn using crowd psychology based on the activity and movement of Brooklyn Immunotherapeuti's stock price.
Brooklyn Immunotherapeuti Current Ratio is fairly stable at the moment as compared to the past year. Brooklyn Immunotherapeuti reported Current Ratio of 5.10 in 2021. Debt to Equity Ratio is likely to rise to 4.30 in 2022, whereas Return on Investment is likely to drop (24.25)  in 2022.

Brooklyn Immunotherapeuti Implied Volatility

    
  504.46  
Brooklyn Immunotherapeuti's implied volatility exposes the market's sentiment of Brooklyn Immunotherapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Brooklyn Immunotherapeuti's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Brooklyn Immunotherapeuti stock will not fluctuate a lot when Brooklyn Immunotherapeuti's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Brooklyn Immunotherapeuti. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Brooklyn Immunotherapeuti to buy its stock at a price that has no basis in reality. In that case, they are not buying Brooklyn because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Brooklyn Immunotherapeuti after-hype prediction price

    
  $ 0.63  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Brooklyn Immunotherapeuti's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Brooklyn Immunotherapeuti in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.204.0910.36
Details
2 Analysts
Consensus
LowTarget PriceHigh
9.0014.5020.00
Details
Earnings
Estimates (1)
LowProjected EPSHigh
-2.79-2.79-2.79
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Brooklyn Immunotherapeuti. Your research has to be compared to or analyzed against Brooklyn Immunotherapeuti's peers to derive any actionable benefits. When done correctly, Brooklyn Immunotherapeuti's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Brooklyn Immunotherapeuti.

Brooklyn Immunotherapeuti After-Hype Price Prediction Density Analysis

As far as predicting the price of Brooklyn Immunotherapeuti at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Brooklyn Immunotherapeuti or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Brooklyn Immunotherapeuti, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Brooklyn Immunotherapeuti Estimiated After-Hype Price Volatility

In the context of predicting Brooklyn Immunotherapeuti's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Brooklyn Immunotherapeuti's historical news coverage. Brooklyn Immunotherapeuti's after-hype downside and upside margins for the prediction period are 0.03 and 6.90, respectively. We have considered Brooklyn Immunotherapeuti's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 0.64
0.63
After-hype Price
6.90
Upside
Brooklyn Immunotherapeuti is very risky asset. Analysis and calculation of next after-hype price of Brooklyn Immunotherapeuti is based on 18 months time horizon.

Brooklyn Immunotherapeuti Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Brooklyn Immunotherapeuti is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Brooklyn Immunotherapeuti backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Brooklyn Immunotherapeuti, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.03  10.75  0.00   0.00  6 Events / Month0 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.640.630.00 
0.00  

Brooklyn Immunotherapeuti Hype Timeline

On the 6th of July Brooklyn Immunotherapeuti is traded for 0.64. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Brooklyn anticipated not to react to the next headlinewith price going to stay at about the same level and average media hype impact volatility of about 0.0%. The immediate return on the next newsis anticipated to be very small whereas the daily expected return is currently at -0.03%. The volatility of relative hype elasticity to Brooklyn Immunotherapeuti is about 15357.14%. The volatility of related hype on Brooklyn Immunotherapeuti is about 15357.14% with expected price after next announcement by competition of 0.64. About 42.0% of the company shares are held by company insiders. The book value of Brooklyn Immunotherapeuti was currently reported as 0.25. The company recorded a loss per share of 0.45. Brooklyn Immunotherapeuti next dividend is scheduled to be issued on the 29th of November 1970. The entity had 3:1 split on the 26th of March 2021. Considering the 90-day investment horizon the next anticipatedpress releasewill be in about 6 days.
Continue to Brooklyn Immunotherapeuti Basic Forecasting Models to cross-verify your projections.

Brooklyn Immunotherapeuti Related Hype Analysis

Having access to credible news sources related to Brooklyn Immunotherapeuti's direct competition is more important than ever and may enhance your ability to predict Brooklyn Immunotherapeuti's future price movements. Getting to know how Brooklyn Immunotherapeuti rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Brooklyn Immunotherapeuti may potentially react to the hype associated with one of its peers.

Brooklyn Immunotherapeuti Additional Predictive Modules

Most predictive techniques to examine Brooklyn price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Brooklyn using various technical indicators. When you analyze Brooklyn charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Brooklyn Immunotherapeuti Predictive Indicators

The successful prediction of Brooklyn Immunotherapeuti stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Brooklyn Immunotherapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Brooklyn Immunotherapeuti based on analysis of Brooklyn Immunotherapeuti hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Brooklyn Immunotherapeuti's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Brooklyn Immunotherapeuti's related companies.
 2019 2020 2021 2022 (projected)
Receivables Turnover3.6511.3510.2111.02
PPandE Turnover0.850.871.01.03

Story Coverage note for Brooklyn Immunotherapeuti

The number of cover stories for Brooklyn Immunotherapeuti depends on current market conditions and Brooklyn Immunotherapeuti's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Brooklyn Immunotherapeuti is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Brooklyn Immunotherapeuti's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Brooklyn Immunotherapeuti Short Properties

Brooklyn Immunotherapeuti's future price predictability will typically decrease when Brooklyn Immunotherapeuti's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Brooklyn Immunotherapeutics often depends not only on the future outlook of the potential Brooklyn Immunotherapeuti's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Brooklyn Immunotherapeuti's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out4.86%
Short Percent Of Float5.42%
Float Shares40.72M
Shares Short Prior Month2.3M
Average Daily Volume Last 10 Day909.91k
Average Daily Volume In Three Month622.72k
Date Short Interest29th of April 2022
Continue to Brooklyn Immunotherapeuti Basic Forecasting Models to cross-verify your projections. Note that the Brooklyn Immunotherapeuti information on this page should be used as a complementary analysis to other Brooklyn Immunotherapeuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Brooklyn Stock analysis

When running Brooklyn Immunotherapeuti price analysis, check to measure Brooklyn Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brooklyn Immunotherapeuti is operating at the current time. Most of Brooklyn Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of Brooklyn Immunotherapeuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brooklyn Immunotherapeuti's price. Additionally, you may evaluate how the addition of Brooklyn Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Is Brooklyn Immunotherapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brooklyn Immunotherapeuti. If investors know Brooklyn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brooklyn Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
30.9 M
Return On Assets
-0.65
Return On Equity
-17.56
The market value of Brooklyn Immunotherapeuti is measured differently than its book value, which is the value of Brooklyn that is recorded on the company's balance sheet. Investors also form their own opinion of Brooklyn Immunotherapeuti's value that differs from its market value or its book value, called intrinsic value, which is Brooklyn Immunotherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brooklyn Immunotherapeuti's market value can be influenced by many factors that don't directly affect Brooklyn Immunotherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brooklyn Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Brooklyn Immunotherapeuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brooklyn Immunotherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.